Psychological Distress — Assessing the Mechanism of Change of Functional Analytic Psychotherapy
Citation(s)
Borckardt JJ, Nash MR Simulation modelling analysis for small sets of single-subject data collected over time. Neuropsychol Rehabil. 2014;24(3-4):492-506. doi: 10.1080/09602011.2014.895390. Epub 2014 Mar 19.
Callaghan, G M. (2006). The Functional Idiographic Assessment Template (FIAT) system: For use with interpersonally-based interventions including Functional Analytic Psychotherapy (FAP) and FAP-enhanced treatments. The Behavior Analyst Today, 7, 357-398. http://dx.doi.org/10.1037/h0100160.
Callaghan, G M., Follette, W. C., Ruckstuhl, L. E., Jr., & Linnerooth, P. J. N. (2008). The Functional Analytic Psychotherapy Rating Scale (FAPRS): A behavioral psychotherapy coding system. The Behavior Analyst Today, 9, 98-116. DOI: http://dx.doi.org/10.1037/h0100648
Hedges LV, Pustejovsky JE, Shadish WR A standardized mean difference effect size for single case designs. Res Synth Methods. 2012 Sep;3(3):224-39. doi: 10.1002/jrsm.1052. Epub 2012 Aug 14.
Kohlenberg, R J., & Tsai, M. (1991). Functional Analytic Psychotherapy: A guide for creating intense and curative therapeutic relationships. New York: Plenum.
Leonard, R C., Knott, L. E., Lee, E. B., Singh, S., Smith, A. H., Kanter, J., Norton, P.J., & Wetterneck, C. T. (2014). The development of the functional analytic psychotherapy intimacy scale. The Psychological Record, 64, 647-657. DOI10.1007/s40732-014-0089-9.
Lovibond PF, Lovibond SH The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995 Mar;33(3):335-43.
Marso, D , and Shadish, W.R. (2014). User Guide for DHPS, D_Power, and GPHDPwr SPSS Macros (Version 1.0). Unpublished manual available from: http://faculty.ucmerced.edu/wshadish/software/software-meta-analysis-single-case-design.
Assessing the Mechanism of Change of Functional Analytic Psychotherapy: An Analysis of a Process-Driven Behavioral Intervention
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
